ABSTRACT. To study the effect of different high-frequency oscillatory ventilation parameters on airway pressure, we measured oscillatory-pressure amplitude (I Pa, I) and mean airway pressure (Pa,) at three sites in openchested normal rabbits: proximal, trachea, and alveolus. Five animals were studied to test a new pleural capsule design, which was then used in two groups of animals to measure right upper (n = 4) or middle (n = 5) lobe alveolar pressures. Animals were randomly sequenced through combinations of frequency (10, 15, and 4, 5, 9-1 1) have identified high-frequency related phenomena, including asynchronous alveolar filling, alterations in the distribution of ventilation, and heterogeneity of both alveolar mean pressure and alveolar pressure amplitude. Although these in vitro results provide some answers concerning the nature of gas flow and distribution during high-frequency ventilation, they do not address the nature of pulmonary pressure distribution under physiologic conditions. Our present research is directed at characterizing a pulmonary pressure profile in an in vivo model with normal gas exchange during HFOV at different parameters of frequency and Ti. Because recent reports have also indicated that the pressures in the alveolar spaces may actually be higher than those measured in the trachea or large airways during some modes of highfrequency ventilation (2-4,9, 10, 12, 13), accuracy in measuring alveolar pressure has become very important. Additionally, the use of a small animal model is highly desirable, as application of HFOV strategies frequently involves the human neonate (14, 15). We have thus taken advantage of the recent development of a fiberoptic, catheter-tipped pressure transducer and have combined this technology with a design for a low-mass miniaturized pressure chamber to create a modified pleural capsule. We have evaluated this new capsule system in vitro and in vivo in a small animal model, and include that evaluation in this report.
I Pa, I, airway pressure amplitude there are limited data on the relationship between proximal, tracheal, and alveolar pressures under conditions simulating clinical high-frequency applications.
However, multiple in vitro studies from several laboratories have provided useful information about high-frequency pulmonary mechanics. These experiments using excised dog lungs (2, 4, 5, 9-1 1) have identified high-frequency related phenomena, including asynchronous alveolar filling, alterations in the distribution of ventilation, and heterogeneity of both alveolar mean pressure and alveolar pressure amplitude. Although these in vitro results provide some answers concerning the nature of gas flow and distribution during high-frequency ventilation, they do not address the nature of pulmonary pressure distribution under physiologic conditions. Our present research is directed at characterizing a pulmonary pressure profile in an in vivo model with normal gas exchange during HFOV at different parameters of frequency and Ti. Because recent reports have also indicated that the pressures in the alveolar spaces may actually be higher than those measured in the trachea or large airways during some modes of highfrequency ventilation (2-4,9, 10, 12, 13), accuracy in measuring alveolar pressure has become very important. Additionally, the use of a small animal model is highly desirable, as application of HFOV strategies frequently involves the human neonate (14, 15) . We have thus taken advantage of the recent development of a fiberoptic, catheter-tipped pressure transducer and have combined this technology with a design for a low-mass miniaturized pressure chamber to create a modified pleural capsule. We have evaluated this new capsule system in vitro and in vivo in a small animal model, and include that evaluation in this report.
Our other experiments use this capsule system in combination with a specialized tracheal pressure monitoring tube and standard pressure monitoring in the ventilator circuit to evaluate proximal, tracheal, and alveolar airway pressures during use of a clinical high-frequency oscillatory ventilator in animals with normal lungs. In this report, we explore the relationshbs of T,, frequency, and airway measurement site on I Paw I and Paw.
Characterization of airway pressure phenomena at the level of the alveolus during high-frequency ventilation has been investigated directly using alveolar capsule measurements (1-6) and indirectly with plethysmography or occlusion equilibrium pressure methodology (7, 8) . Only two of these reports (1, 6) involve direct pressure measurements in an in vivo system. As a result, 1 -mm flange around the outer circumference served as a bonding surface to the lung, providing 0.404 cm2 of area. A small hole (0.07 mm) was drilled in the top of the capsule to allow the introduction of a 27-gauge needle to pierce the pleural surface. The capsule was sealed to the lung with cyanoacrylate (Krazy Glue, Kiasca, IL), which was applied using a syringe and a 24-gauge angiocatheter for maximum flow control of the adhesive. Three punctures were made through the pleura using a marked needle so that the puncture depth was uniformly 1.7 mm, allowing pressure equilibration between the alveoli and the chamber. The top hole in the capsule was then sealed with rubber cement. A port in the side of the capsule (1.35 mm inner diameter) was used to introduce the 4 F fiberoptic catheter-tipped pressure transducer (model 420, Camino Inc., San Diego, CA) into the capsule cavity. Rubber cement was also used to seal this port and to secure the transducer to the chamber.
The capsule mass was 129 -t 5 mg (mean f SD, n = 5). With the fiberoptic catheter transducer inserted into the capsule, the total mass of the alveolar pressure sensor unit was 430 mg. The low-mass capsule and transducer are shown in Figure 1 . The pressure-sensitive component in the fiberoptic catheter pressure transducer is a deformable membrane in a small cavity at the tip of the catheter. The outside surface of the deformable membrane is exposed to the pressure in the surrounding media. The catheter contains two optical fiber bundles. Light is transmitted through one fiber bundle and shone on the polished inside surface of the deformable membrane. Reflected light returns through the second fiber bundle to a signal detection and processing unit. Within this unit, light is detected and the intensity of reflected light is converted to a voltage that is proportional to the gauge pressure on the deformable membrane.
The frequency response of the transducer/capsule system was evaluated using the techniqes of Jackson and Vinegar (16) . Calibration signals for the capsule system, the tracheal airway pressure measurement tube (described below), and a reference transducer (model 239, Setra Systems, Inc., Acton, MA) were compared using a frequency spectrum waveform analyzer (model 3682A, Hewlett-Packard Co., Palo Alto, CA) and a random frequency driver. The transfer functions of the reference and each test transducer system were compared. For the capsule system, an in situ calibration was also performed. The capsule opening was covered with tape to simulate a pleural surface and the tape punctured three times with a 27-gauge needle. This in situ system was then compared with the reference transducer.
In vivo protocol. Five New Zealand White rabbits were anesthetized with an intramuscular injection of a mixture containing 3 mg/kg of xylazine, 1.5 mg/kg of acepromazine, and 30 mg/kg of ketamine. An arterial line was placed in the ear and used for extraction of blood gases. Similarly, an ear vein was cannulated for administration of i.v. fluids and medications. The animals were intubated via a tracheostomy with a 3.0-mm outer diameter endotracheal tube, paralyzed with 0.2 mg/kg pancuronium bromide i.v., and ventilated with a high-frequency oscillatory ventilator (model 3200, SensorMedics, Dayton, OH). The animals continued to receive i.v. pancuronium bromide and ketamine (10 mg/kg) throughout the experiment. When the rabbit was stable, a right thoracotomy was performed. The low-mass pleural capsule was applied to the central portion of the right middle lobe after a calibration check of the fiberoptic transducer. Once the capsule was in place, signal integrity was verified by observation of the capsule pressure waveform.
Tracheal pressures were measured using a +I00 cm H 2 0 pressure transducer (model MP45, Validyne Engineering Corp., Northridge, CA), which was connected to a 12-cm, 18-gauge stainless steel tube using a Luer stub and 5 cm of stiff plastic tubing. The stainless steel pressure-monitoring tube was fastened to the endotracheal tube and had a 25-gauge side port placed perpendicular to the trachea 2 cm below the distal opening of the endotracheal tube. Calibrations of both the alveolar and tracheal transducer systems could be statically verified by interrupting HFOV for a few seconds, allowing tracheal and alveolar pressure to equilibrate to the same mean pressure.
Pressure waveform signals were recorded without filtering at a sampling rate of 500 samples/s using a laboratory computer (model 500, MASSCOMP, Westford, MA). For each data set, values of peak, trough, and mean airway pressures were averaged over three oscillations. Pressure amplitude was calculated as the difference between peak and trough airway pressures.
The effect of increased capsule mass on measured pressures was evaluated by attaching calibrated weights to the top of the right middle lobe capsule. One-and 2-g weights were added to increase the system mass to 1.4 g and 2.4 g, respectively. Three to four data sets were collected at baseline (no added weight), after addition of each calibrated weight, and again after return to baseline with removal of the added weight. Alveolar and tracheal I Paw I and paw values were averaged across data sets for each weight. In one animal, after successful placement of the first capsule, a second capsule was placed on the middle lobe and measurements were taken with a 1-g weight.
For these studies, the HFOV settings were chosen to obtain normal blood gas values. Ventilator frequency (15 Hz), Ti (0.3), fraction of inspired oxygen (30%), and mean airway pressure (5 Fig. 1 . Photo of the assembled low-mass pleural chamber and fiberoptic catheter tip transducer, which compose the modified alveolar capsule. Dimensions of the chamber are 2.9 mm inner diameter X 3.9 mm high with a total volume of 23 ~L L .
Mass of the chamber and transducer is 430 mg. The capsule is applied to the exposed pleural surface with cyanoacrylate.
AIRWAY PRESSURES DURING HFOV 369 cm H 7 0 ) were held constant. whereas ventilation was controlled by small'adjustrnents in ventilator pressure amplitude.
IIFOV E.vperirnenrs. Animal model. Nine Pasteurella-free New Zealand white adult rabbits were given initial sedation and anesthesia and prepared for thoracotomy as described above. These animals were connected to a pressure-limited, time-cycled infant ventilator (Bear Cub, Bourns Inc., Riverside, CA) on a fraction of inspired oxygen of 0.28 with rate and pressure adjusted to yield a normal arterial blood gas (pH 7.33-7.73, arterial COz pressure 1 1-28 torr, arterial O2 pressure 79-108 torr) (1 7).
A right parasternal thoracotomy was accomplished with exposure of the right middle and upper lobes. In four animals, a pleural capsule was applied to the right upper lobe, and in five animals the capsule was placed on the right middle lobe. The animals received pancuronium bromide and ketamine throughout the experiment as noted previously.
Pressure measurements. Proximal airway pressure was measured via a pressure port at the endotracheal tube connector (Respiratory Support Products, Inc., Newport Beach, CA) using a k 150 cm H 2 0 pressure transducer (model MP45, Validyne).
Airway pressure within the trachea was measured with the already described stainless steel pressure monitoring tube, and alveolar pressures with the low-mass pleural capsule.
All three pressure signals were monitored simultaneously and recorded as abcve. Representative waveforms were averaged over 2-s epochs for Paw. Cycle peak and trough airway pressures were determined from which I Paw I was calculated and averaged over the epoch.
Experimental protocol. When the animal was stable after surgery and pleural capsule placement, ventilation was switched from conventional ventilation to HFOV. By design, each animal was randomly sequenced through six combinations of frequency (10, 15, 20 Hz) and Ti (0.3, 0.5). At each new ventilator setting combination, proximal I Pa, I and paw were adjusted to yield normal rabbit arterial blood gas values. After verification of the arterial blood gas, measurements were recorded from each of the three measurement sites and then the sequence was repeated for the next combination of Ti and frequency. Throughout our protocol, we interspersed maneuvers for confirming the accuracy of our alveolar measurements, frequently discontinuing oscillations and placing the ventilator in a constant pressure mode to document that proximal and capsule steady-state pressures were identical.
Data analysis. The effect of added mass on alveolar and tracheal pressures was tested using one-way analysis of variance with statistical significance considered to be achieved at the p < 0.05 level.
To test th_e effect of frequency, Ti, and measurement site on I Paw I and Pa,, we first performed a multifactorial analysis of variance to evaluate for main effects ( p < 0.05). Where no effect was seen, data were subsequently reduced on that parameter. Where significant effects were noted, more detailed analyses were performed. These included one-way analysis of variance with Fisher least significant difference comparisons for the evaluation of between-site pressures for each group and Ti value. Also performed was a two-way analysis of variance (groups versus site) at each Ti setting with post hoc t tests using a Bonferonni correction for three comparisons ( p < 0.017). These tests were performed to identify specific sites where airway pressures differed between the two animal groups. Similarly, a two-way analysis of variance was performed (Ti versus site) for each group withjmilar post hoc tests to determine the effect of Ti on I Pa, I
and Pa,.
RESULTS
Pressure measurement systems. The frequency characteristics of the tracheal and alveolar measurement systems were evaluated and compared with the reference transducer. For the tracheal pressure measurement system, the response was flat to 80 Hz and 2.5 decibels down at 100 Hz. The phase difference was 0" up to 50 Hz and less than 10" at 100 Hz. For the alveolar pressure measurement system, the response was flat to greater than 40 Hz and 3 decibels down at 100 Hz. There was a linear phase shift with respect to the reference transducer that was 150" at 100 Hz. The transfer functions for the simulated in situ capsule system were the same as those without the punctured pleural surface. These results indicate that the amplitude response of both measurement systems was adequate for the ventilatory parameters (Fig. 2a) . Tracheal I Paw I was unaffected by capsule mass.
With the 1-g added mass, capsule Paw increased by 16% compared with the baseline pressure. When the 2-g mass was added, Paw increased by 32%. This effect of increasing capsule mass on paw was statistically significant ( p < 0.05), and is shown graphically -in Figure 26 . When the mass was removed, capsule Paw returned to the original value. There was no effect on tracheal -Paw as capsule mass was increased.
HFOV experiments. Upper and middle lobe alveolar mechanics were evaluated in separate animal groups whose ventilator parameters were adjusted to normalize blood gas values. The results of the multifactorial analysis of variance are presented in Table 1 . Ventilator frequency-appeared to contribute little to the variation in either I P a w l or Paw. However, effects are noted for the interaction o f x , on Paw, and for airway site on the variability in both Paw and I Paw 1. The relationships between T,, frequency, airway measurement site, and airway pressures are presented in Figures 3 and 4 . More detailed analyses are exhibited in Tables  2 and 3 , where the data have been compressed across frequeccies, justified due to the lack of effect of frequency on I Pa, I or Paw. Tables 2 and 3. I Po, I. The behavior of the dynamic component of the highfrequency oscillations is shown in Figure 3 . There were no differences at any site between groups (Table 3) , so group values were combined and plotted. Within each group, increasing Ti from 0.3 to 0.5 did not cause significant changes in I Paw I at any site ( Table 3 ). The amplitude of the pressure oscillations, I Pa, 1, followed a consistent pattern. We found a progressive attenuation in I Pa, 1, moving from proximal to trachea to alveolus ( Po,,. The values for paw by frequency and site are depicted in Figure 4 . Because no between-group differences were seen in Paw in proximal and tracheal measurements ( Table 3) , these values were combined and plotted. Significant changes across sites are seen in each animal group at each T, yalue ( Table 2) 
DISCUSSION
Our study demonstrates the measurement of alveolar pressures using a system of reduced size and mass compared with capsule systems that have been previously reported (2, 3, 5, 6, 9, 18) . The system is shown by in vitro testing to have excellent signal fidelity with no loss of resolution or sensitivity within the frequency range of potential high-frequency ventilation. However, use of the capsule system for real time comparison of different airway sites or different pleural surface locations would require compensation for a phase difference of 15-20" at 15 Hz.
Previous reports using similar systems to estimate alveolar pressures have used pleural capsules weighing from 3 to 9 g (I-3, 5,6,9, 18). In contrast, we have used a capsule system weighing considerably less (430 mg). Because the heavier capsules were also larger than those used in our studies, it is possible that point forces on the visceral pleura were lower due to greater surface contact area. Calculated surface forces developed by the system described in this paper are (0.43 g X 980.7 cm/s2)/(0.40 cm2) = 1044 dynes/cm2. Based on data available by Fredberg et al. (9) and McNamara et al. (5) , we calculated the surface forces for the 3-g capsule/transducer system used in their studies to be (3 g x 980.7 cm/s2)/(1.5 cm2) = 1961 dynes/cm2, or 88% higher.
The lighter system used in our experiments would necessarily present a lower mechanical load to the lung parenchyma. This is in agreement with our observations that even slight pressures externally applied to the capsule caused marked elevations in the capsule pressure. In fact, we found that addition of a 2-g weight caused mean alveolar pressures to increase by 32%.
The mechanism by which pleural compression might cause an increase in capsule pressure is unclear. Tissue compression may cause terminal airway narrowing or valving resulting in local gas trapping. This in turn could result in an increase in local alveolar volume and an increase in the pressure measured in the capsule. The same mechanism could also explain the increase in alveolar pressure amplitude that we saw with increasing capsule mass. As parenchymal compression increased, closing off neighboring connecting alveolar spaces, local compliance would decrease, causing higher pressure swings for equivalent volume fluctuations. The reports by Frantz and Close (1) and Fredberg et al. (9) noted that alveolar pressure measured at the capsule was not altered by increasing capsule mass from 3 g up to 9 g. These differences with our study may be related to different lung structure characteristics of the two animal models. They may also be related to other protocol differences, such as the number, diameter, and depth of pleural punctures. The geometry of these access holes is unknown in relation to their penetration below the pleura into alveolar sacs or distal airways. The creation of small bronchiolar-pleural-capsule fistulae could be possible and would increase the likelihood of measuring distal airway pressure changes rather than alveolar pressure changes. One would expect relatively little effect of small pleural loads on the pressure in such airways.
The experiments using this low-mass capsule system to measure alveolar pressure during HFOV were very revealing. These data demonstrate that upper lobe alveolar &, measured in one group of animals is lower compared with a second group of animals where alveolar Paw was measured in the middle lobe during HFOV. Furthermore, the upper lobe alveolar pressures were lower than pressures measured in the trachea, and these findings were independent of Ti or frequency. T,, however, did have a profound influence on Paw in the trachea and in the middle lobe alveolus, causing these pressures to increase as Ti increases. In addition I Pa, I was significantly attenuated during transmission across the endotracheal tube, and decreased further when measured at the alveolus.
The attenuation of I Paw I across the endotracheal tube is a complex filtering process, a function of endotracheal tube physical characteristics and pressure waveform frequency composition (19) . Considering the noisy character of the proximal pressure waveform for this type of HFOV device, it was not surprising that endotracheal tube filtering was significant. We found a 97% decrement in amplitude in the trachea. Furthermore, we measured an additional 75% decrease in I Paw I between the trachea and alveolus, similar to that predicted by Niederer et al. (20) .
Under the physiologic conditions of this experiment, we did not see resonant amplification in the alveolus (i.e. alveolar ( Pa, ( > tracheal I Paw I) at the frequencies tested, as previously reported in isolated lungs for small-amplitude oscillations (3, 9) . Although the magnitude of alveolar I Pa, I was always small in a clinical sense, being on the order of 1 cm H20, it still probably fell in the realm of nonlinear behavior for large-amplitude oscillations and, thus, the observations of Allen et al. (3) and Fredburg et al. (9) may not apply. On the other hand, if cyclic stretch in a poorly compliant lung is a factor in the etiology of pulmonary injury, then HFOV, as demonstrated by relatively low amplitude alveolar I Pa, I in this model, should be an ideal mode of ventilation to reduce or preve_nt baroinjury. We found that Pa, was always less in the upper lobe than in the middle lobe. Similar findings have been reported in excised dog lungs (4). These results imply that the interlobe heterogeneity is neither species-specific nor absent in the intact animal and confirm that preferential distention of the basilar region and regional volume distribution inhomogeneities occur in lungs ventilated with HFOV. Interlobe heterogeneity is known to be position dependent (lo), which could explain our findings and perhaps those of others (2,4). The mean pressure inhomogeneity, however, may also be a function of airway geometry (4) . If so,it is reasonable to expect intralobar heterogeneity in alveolar Paw as well, although this has yet to be demonstrated (1 1).
Airway pressures varied considerably in response to changes in T, during HFOV. We found that as T, increased from 0.3 to 0.5, tracheal and middle lobe alveolar paw increased at each frequency tested. This was a dynamic phenomenon that disappeared when the animal was sighed or placed on continuous positive airway pressure. From a clinical point of view, this obsemation has great significance because there was no noticeable change in pressures at the proximal site, where ventilator pressure monitoring measurements are commonly accomplished. Proper clinical management requires using proximal airway pressures to estimate tracheal and alveolar pressures. Our study indicates that although this might be safe when T, = 0.3, the situation becomes less predictable as inspiratory time approaches expiratory time.
In general, increases in tracheal and alveolar pressures, such as those seen in our experiments at T, = 0.5, occur when expired volume is less than the inspired volume. When the expiratory time is decreased (i.e. T, increases while the ventilation frequency remains constant), the average expiratory flow over one cycle must increase to produce the same expired volume in the shorter allowed time. If some mechanism prevents the required increase in flow, increased lung volumes and pressures will result.
This could occur if the pressure gradient between the alveoli and ventilator is too small to provide the necessary increase in flow. During conventional ventilation, this pressure gradient is the difference between alveolar pressure and continuous distending pressure. In the oscillatory ventilator, this pressure is the difference between alveolar pressure and the pressure created within the ventilator during expiration, which can be well below atmospheric pressure. Thus, the oscillator can create much larger pressure gradients, and much larger flows. The larger flows make it less likely that the oscillator, a device with an "active" expiration phase, would cause an increase in alveolar and tracheal pressure when T, is increased, compared with ventilators that rely solely on passive expiration (2 1). Our data, however, would suggest that HFOV can also demonstrate this effect, but at a relatively low absolute level. Higher alveolar pressures would contribute to increasing lung volume. Lung hyperinflation during HFOV has been documented in several animal models (22) (23) (24) and in humans (12) within frequency ranges similar to those in our study (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) .
Although we did not measure lung volume, we provide suggestive evidence that at T, = 0.3 lung hyperinflation secondary to HFOV is unlikely, inasmuch as alveolar mean pressure is less than proximal mean pressure.
Expiratory resistance exceeding inspiratory resistance is a second mechanism that could reduce expiratory flow. Viscous and turbulent flow dissipation has been shown to depend on local airway compliance (25) , which varies with inspiration and expiration. Differences in inspiratory and expiratory resistance based on geometry have also been demonstrated (26) , and this factor may also play a role.
The increases in tracheal pressure measured when T, = 0.5 may be due to an effect of the endotracheal tube. When T, = 0.3, the mean flow (velocity) through the endotracheal tube during inspiration must be twice that during expiration if the inspiratory and expiratory volumes are to be equal. However, the resistance varies as the square of the mean velocity (27) , so that doubling the mean velocity must result in an inspiratory resistance that is considerably higher than the expiratory resistance. The effect of this large inequality between inspiratory and expiratory pressure drop on flow, when averaged over the ventilator cycle, results in a tracheal mean pressure that is lower than the proximal mean pressure. This is demonstrated in our results shown in Figure 4 . However, when Ti is increased to 0.5, the mean velocities become equal. This leads to an increase in the mean tracheal pressure compared with when Ti = 0.3. Figure 4 also shows this expected increase in tracheal pressure. That tracheal mean pressures actually exceeded proximal mean pressures at T, = 0.5 implies some degree of inspiratory/expiratory asymmetry in the oscillator pressure waveform, or that Ti, although indicated as 0.5, may have slightly exceeded 0.5, causing operation at a reversed inspiratory to expiratory ratio.
If one or more of these mechanisms operates during HFOV, then a residual of the inspired volume remains in the airways, causing tracheal and alveolar Pa, to increase. Once tracheal Pa, increases to a level that establishes a sufficient expiratory pressure gradient, inspired and expired volumes will be equal and pressures will stabilize at a new equilibrium level.
In summary, we have studied the effect of changes in frequency and T, during HFOV on the transmission of pressure through the airways to the alveolus. Using a low-mass alveolar capsule in a physiologic open-chest rabbit model, we have noted Pa, inhomogeneity between upper and middle lobes and an effect of Ti on tracheal and alveolar pressures. Ventilator frequency appeared to have little effect on pressure transmission within the realm of ventilator parameters used in this study. There was marked attenuation of the oscillatory amplitude over the entire airway. Of special clinical importance is the fact that changes in airway pressure in the trachea or in the alveolus were not reflected in proximal pressure measurement within the ventilator circuit, the most common location for clinical monitoring.
